Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial

INTRODUCTION: Irritable bowel syndrome (IBS) is characterised by the association of abdominal chronic pain with bowel habit disorders in the absence of identifiable organic disease. This is the first reason for consultation in gastroenterology, with an estimated prevalence of 10%–15% in industrialis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerckhove, Nicolas, Scanzi, Julien, Pereira, Bruno, Ardid, Denis, Dapoigny, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734298/
https://www.ncbi.nlm.nih.gov/pubmed/28720615
http://dx.doi.org/10.1136/bmjopen-2016-015380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734298/
https://www.ncbi.nlm.nih.gov/pubmed/28720615
http://dx.doi.org/10.1136/bmjopen-2016-015380

Ejemplares similares